Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Gibbs

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Marine Biotechnology (New York, N.Y.)|August 20, 2003
Polyketide synthase genes from marine dinoflagellatesR V Snyder, P D L Gibbs, A Palacios, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, A L Colombo, et al.
Journal of Pediatric Surgery|April 30, 2003
Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's disease: Implications for surgical approachM L Proctor, J Traubici, J C Langer, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, M Mendez, et al.
Journal of Clinical Microbiology|December 14, 2007
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|January 18, 2008
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|December 8, 2005
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testingM A Pfaller, D J Diekema, M G Rinaldi, et al.
Journal of Clinical Microbiology|February 19, 2010
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusionM A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|April 13, 2007
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofunginA Espinel-Ingroff, B Arthington-Skaggs, N Iqbal, et al.
Journal of Clinical Microbiology|May 6, 2011
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous FungiA Espinel-Ingroff, E Canton, A Fothergill, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Marine Biotechnology (New York, N.Y.)|August 20, 2003
Polyketide synthase genes from marine dinoflagellatesR V Snyder, P D L Gibbs, A Palacios, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, A L Colombo, et al.
Journal of Pediatric Surgery|April 30, 2003
Correlation between radiographic transition zone and level of aganglionosis in Hirschsprung's disease: Implications for surgical approachM L Proctor, J Traubici, J C Langer, et al.
Journal of Clinical Microbiology|October 6, 2006
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance programM A Pfaller, D J Diekema, M Mendez, et al.
Journal of Clinical Microbiology|December 14, 2007
Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|January 18, 2008
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005M A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|December 8, 2005
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testingM A Pfaller, D J Diekema, M G Rinaldi, et al.
Journal of Clinical Microbiology|February 19, 2010
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusionM A Pfaller, D J Diekema, D L Gibbs, et al.
Journal of Clinical Microbiology|April 13, 2007
Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofunginA Espinel-Ingroff, B Arthington-Skaggs, N Iqbal, et al.
Journal of Clinical Microbiology|May 6, 2011
Quality control guidelines for amphotericin B, Itraconazole, posaconazole, and voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller-Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous FungiA Espinel-Ingroff, E Canton, A Fothergill, et al.
Pageof 5